治疗未婚女性解脲支原体感染的临床研究

来源 :中国妇幼保健 | 被引量 : 0次 | 上传用户:Luke_ibox
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨治疗未婚女性解脲支原体感染的效果。方法:对202名自愿接受本次调查的未婚(有性生活史)女性进行宫颈分泌物培养及药敏,将检测阳性的109例患者随机分为研究组59例和对照组50例;对照组常规治疗。研究组在常规治疗的基础上加敏感药物局部用药10~14天,治疗后4、12周及6个月随访。结果:研究组6个月后复发2例,复发率18.00%;对照组6个月后复发7例,复发率38.90%,两组比较差异有统计学意义(P<0.01)。结论:重视并提倡对未婚女性常规进行支原体培养及药敏,选择敏感药物在常规治疗的基础上加局部用药疗效可靠,可明显降低未婚女性解脲支原体感染复发率。 Objective: To explore the effect of treating UU women infected with Ureaplasma urealyticum. Methods: Totally 202 unmarried women (sex life history) women who volunteered for this survey were subjected to cervical secretion culture and drug susceptibility. The 109 patients with positive test were randomly divided into study group (59 cases) and control group (50 cases). The control group Conventional treatment. The study group on the basis of conventional treatment plus sensitive drugs topical drug for 10 to 14 days, 4,12 weeks and 6 months after treatment follow-up. Results: In the study group, 2 cases relapsed 6 months later, the recurrence rate was 18.00%. In the control group, 7 cases relapsed after 6 months, the recurrence rate was 38.90%. There was significant difference between the two groups (P <0.01). CONCLUSION: It is emphasized and advocated that the unmarried women routinely carry on mycoplasma culture and drug sensitivity. The selection of sensitive drugs on the basis of routine treatment plus topical treatment is reliable and can significantly reduce the recurrence rate of un U women ’s Ureaplasma urealyticum infection.
其他文献